Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02429986
Other study ID # 9498
Secondary ID 2014-A01565-42
Status Completed
Phase N/A
First received
Last updated
Start date March 13, 2015
Est. completion date January 17, 2017

Study information

Verified date September 2020
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Adaptive Servo-Ventilation (ASV) treatment is routinely prescribed in France. In order to be reimbursed according to the French Social Security rules, the patient treated with an ASV needs to be examined each year. In this observational transversal single-visit study, the investigators aim to describe the clinical characteristics of patients treated with ASV and the associated device settings.


Description:

The purpose of this study is to evaluate in "real life conditions" the use of Adaptative Servo-Ventilation (ASV) treatment. ASV treatment is routinely prescribed in France in patients with various sleep disorders breathing (Chronic Heart Failure (CHF) and Central Sleep Apnea Syndrome (CSAS), CHF and central and obstructive sleep apnea (COSA), Obstructive Sleep Apnea Syndrome (OSAS) and complex sleep apnea syndrome (compSAS), idiopathic or drug induced periodic breathing.

In order to be reimbursed according to the French Social Security rules, the patient treated with an ASV needs to be examined each year. In this observational transversal single-visit study, the aim is to describe the clinical characteristics of patients treated with ASV and the associated device settings. The aim is to evaluate the safety and efficacy issues in real life conditions of the ASV prescription.Depending of the data, data are obtained after analysis of the six latest months data of the ASV device, after questioning the patient, after analysis of the polygraphy/oximetry (if prescribed by the doctor for the renewal consultation of the ASV care and reimbursement by the French Social Security). All the data are obtained during the annual consultation required by the French Social Security.


Recruitment information / eligibility

Status Completed
Enrollment 214
Est. completion date January 17, 2017
Est. primary completion date January 17, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Written informed consent

- Age more than 18 years (inclusive)

- Patient treated with ASV for at least one year,and eligible for care and for the reimbursement by the French Social Security rules.

- Patient presenting at the annual control consultation for the continuation of the ASV treatment according to the French Social Security rules.

Exclusion Criteria:

- Pregnancy, intention of being pregnant, breastfeeding.

- Inability to understand the nature and aims of the study or to communicate with the investigator

- Simultaneous participation in another trial with an exclusion clause to participate to an other trial.

- No affiliation to the French social security

- Loss of personal capacity resulting in state protection

- Deprivation of liberty by judicial or administrative decision

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Adaptive Servo-Ventilation
Adaptive Servo-Ventilation proceeds by continually measuring either minute ventilation or airflow and calculates a target ventilation to be applied as needed.

Locations

Country Name City State
France Polyclinic Saint-Privat Boujan sur Libron
France CHU Dijon Dijon
France Hôpital Nord Marseille
France Arnaud de Villeneuve University Hospital Montpellier
France Hôpital Pitié Salpetrière Paris

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

References & Publications (3)

Jaffuel D, Mallet JP, Combes N, Palot A, Rabec C, Molinari N, Jaber S, Bourdin A. [Adaptive servo-ventilation after the SERVE-HF study: The swan song?]. Rev Mal Respir. 2016 Sep;33(7):641-4. doi: 10.1016/j.rmr.2016.04.001. Epub 2016 May 5. French. — View Citation

Jaffuel D, Philippe C, Rabec C, Mallet JP, Georges M, Redolfi S, Palot A, Suehs CM, Nogue E, Molinari N, Bourdin A. What is the remaining status of adaptive servo-ventilation? The results of a real-life multicenter study (OTRLASV-study) : Adaptive servo-v — View Citation

Jaffuel D, Rabec C, Philippe C, Mallet JP, Georges M, Redolfi S, Palot A, Suehs CM, Nogue E, Molinari N, Bourdin A. Patterns of adaptive servo-ventilation settings in a real-life multicenter study: pay attention to volume! : Adaptive servo-ventilation set — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Residual Apnea Hypopnea Index (AHI) evaluated by the ASV device and associated pressure settings Relationship between the residual AHI and the associated pressure settings, in function of the phenotype of the patients (presence or absence of cardiopathy, presence or absence of altered left ventricular ejection fraction (=45% or > 45%) The measures are performed during the annual consultation required by the French Social Security for the renewal of the reimbursement of the ASV care. The measures are obtained after analysis of the six latest months data of the device.
Secondary Sleep Disorder Breathing involved in the initial prescription of ASV The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security). The day of inclusion
Secondary ASV compliance (number of hour per day, number of day with =3 hours in the past 6 months) The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security). The day of inclusion during the consultation or in a maximum delay of 15 days after (if the patient forgot to bring his device)
Secondary Type of device used nad history of device used (CPAP used before ASV ?) The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security) The day of inclusion during the consultation or in a maximum delay of 15 days after (if the patient forgot to bring his device)
Secondary Used or not of an auto-EPAP The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security). The day of inclusion during the consultation or in a maximum delay of 15 days after (if the patient forgot to bring his device)
Secondary Settings of the device (Inspiratory and Expiratory pressures, duration of pressurization, backup frequency) The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security). The day of inclusion during the consultation or in a maximum delay of 15 days after (if the patient forgot to bring his device)
Secondary Type of mask used and historical use of mask The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security). The day of inclusion during the consultation or in a maximum delay of 15 days after (if the patient forgot to bring his device)
Secondary Changes in AHI as compared to baseline The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security). The day of inclusion during the consultation or in a maximum delay of 15 days after (if the patient forgot to bring his device)
Secondary Changes in Daytime Sleepiness by measuring Epworth scale as compared to baseline if available The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security). The day of inclusion
Secondary Changes in Asthenia by measuring Pichot scale as compared to baseline if available The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security). The day of inclusion
Secondary Number of hospitalization during the last year and etiology of the hospitalization The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security). The day of inclusion
Secondary Presence of a cardiomyopathy The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security). The day of inclusion
Secondary Treatment of the cardiomyopathy (medication consumption and use of cardiac implant will be reported) The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security). The day of inclusion
Secondary Number of patients not showing up for the annual consultation The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security). One year after the start of the study
See also
  Status Clinical Trial Phase
Completed NCT00915499 - Complex Sleep Apnea Syndrome (CompSAS) Resolution Study N/A